2010 AnnuAl REpoRT - Ciberdem
2010 AnnuAl REpoRT - Ciberdem
2010 AnnuAl REpoRT - Ciberdem
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Keyword index*<br />
Beta-cell signal transduction. . . 34, 92, 97, 101, 115, 121<br />
Bioinformatics . . . . . . . . . . . . . . . . . . . . . . 36<br />
Biomarkers and Imaging. . . . . . . . . . . . . 36, 62, 69<br />
Carbohydrate metabolism . . . . . . . . . . . . 40, 42, 48<br />
Cardiac complications . . . . . . . . . . . . . . . . . . 85<br />
Catecholamines . . . . . . . . . . . . . . . . . . . . 107<br />
Clinical diabetes . . . . . . . . . . . . . . . .76, 103, 111<br />
Clinical trial. . . . . . . . . . . . . . . . . . . . . . . 115<br />
Cytokines. . . . . . . . . . . . . . . . 38, 44, 54, 65, 121<br />
Endothelium . . . . . . . . . . . . . . . . . .69, 111, 124<br />
Epidemiology. . . . . . . . . . . . . . . . . . . . . 73, 81<br />
Exercise . . . . . . . . . . . . . . . . . . . . 38, 48, 124<br />
Gastro-entero pancreatic factors . . . . . . . . . 92, 118<br />
Gene therapy. . . . . . . . . . . . . . . . . . . . . . . 97<br />
Genetics type 1 diabetes . . . . . . . . . . . . . . . 103<br />
Genetics type 2 diabetes . . . . . . . 56, 69, 73, 94, 109<br />
Genomics . . . . . . . . . . . . . . . . . . . 48, 73, 109<br />
Glucose transport . . . . . . . . . . . . . . . . . . 38, 46<br />
Hormone receptors . . . . . . . . . .44, 46, 94, 107, 121<br />
Hormones (non-insulin), action . . . . . . . . . . . . 121<br />
Incretins . . . . . . . . . . . . . . . . . . . . . . . 46, 94<br />
Insulin action . . . . . . . . . . . . . . . . . . . 44, 48, 92<br />
Insulin secretion . . . . . . . . . . . . . . . . . . . . 121<br />
Insulin sensitivity and resistance 34, 38, 40, 42, 44, 46, 48,<br />
59, 62, 65, 69, 85, 87, 92, 97, 101, 107, 121<br />
Insulin synthesis . . . . . . . . . . . . . . . . . . . . 127<br />
Insulin therapy . . . . . . . . . . . . . . . . . . . . . . 81<br />
Islet amyloid polypeptide/amylin. . . . . . . . . . . . 124<br />
Islet degeneration and damage . . 92, 101, 111, 115, 118,<br />
124, 127<br />
Islet development . . . . . . . . .107, 109, 111, 115, 127<br />
Islet transplantation . . . . . . . . . . . . . . . . . . 118<br />
Lipid metabolism. . . . . 38, 40, 46, 48, 54, 56, 59, 76, 85<br />
Lipid signalling . . . . . . . . . . . . . . . . . . . . . . 54<br />
Lipids, lipoproteins . . . . . . . . . . . . . . . . 36, 56, 85<br />
Macrovascular disease . . . . . . . . . . . . . 34, 59, 69<br />
Metabolic surgery . . . . . . . . . . . . . . . . . . . . 62<br />
Metabolic syndrome . 42, 54, 56, 59, 65, 69, 73, 76, 81, 87<br />
Metabolomics . . . . . . . . . . . . . . . . . . . . . . 36<br />
Monogenic diabetes . . . . . . . . . . . . . . . . . . 103<br />
Neuropathy-somatic . . . . . . . . . . . . . . . . . . . 97<br />
Nutrigenomics . . . . . . . . . . . . . . . . . . . . . . 69<br />
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . 101<br />
Oral pharmacological agents . . . . . . . 42, 48, 65, 103<br />
Paediatrics . . . . . . . . . . . . . . . . . . . . . . . . 65<br />
Pathogenic mechanisms . . . . . . . . . . . . . . . 34, 56<br />
Phospholipases . . . . . . . . . . . . . . . . . . . . . 54<br />
Polycystic ovary syndrome. . . . . . . . . . . . . . . . 62<br />
PPAR . . . . . . . . . . . . . . . . . . . . . . . . . . . 85<br />
Prediction/prevention type 1 diabetes . . . . . . . . . 103<br />
Prediction/prevention type 2 diabetes . . . . . . . . 81, 87<br />
Pregnancy . . . . . . . . . . . . . . . . . . . . . . . . 87<br />
Prevention of type 1 diabetes . . . . . . . . . . . . . . 73<br />
Prevention of type 2 diabetes . . . . . . . . . . . . 65, 69<br />
Proinsulin. . . . . . . . . . . . . . . . . . . . . . . . 107<br />
Protein metabolism. . . . . . . . . . . . . . . . . . . . 48<br />
Proteomics . . . . . . . . . . . . . . . . . . . . . . 62, 73<br />
Retinopathy. . . . . . . . . . . . . . . 42, 44, 76, 97, 101<br />
Stem cells . . . . . . . . . . . . . . 48, 94, 101, 115, 118<br />
Transcription factors . . . . . . . . . 48, 85, 109, 124, 127<br />
Weight regulation and obesity . .34, 44, 59, 76, 81, 87, 94,<br />
111, 118<br />
*Source: DIAMAP, Road Map for Diabetes Research in Europe.<br />
132 CibeRdem